Business Context and Reporting Period
This Form 8-K Current Report was filed by Relmada Therapeutics, Inc. on December 6, 2019, covering events occurring on December 3, 2019. The filing details the entry into a material definitive agreement regarding an underwritten public offering of common stock.
Key Financial Metrics
- Offering Size: 3,333,334 shares of common stock initially offered, plus an additional 500,000 shares purchased via the underwriters' full exercise of their option.
- Public Offering Price: $30.00 per share.
- Price to Underwriters: $28.20 per share.
- Estimated Net Proceeds: Approximately $107.7 million (including proceeds from the option exercise).
- Closing Date: December 6, 2019.
Material Changes
The primary material change reported is the successful completion of a capital raise. The Company entered into an Underwriting Agreement with Jefferies LLC and SVB Leerink LLC. The underwriters exercised their option to purchase additional shares in full on December 4, 2019, increasing the total capital raised compared to the initial offering size.
Outlook, Risks, and Management Commentary
The filing confirms the closing of the offering and the receipt of estimated net proceeds. The Underwriting Agreement includes customary representations, warranties, and indemnification provisions where the Company agrees to indemnify the Underwriters against certain liabilities under the Securities Act of 1933. The filing does not provide specific forward-looking guidance on revenue or operational milestones, nor does it detail specific risks beyond standard underwriting liabilities.
Investor Verification Checklist
- Verify the final closing date and actual net proceeds received versus the estimated $107.7 million.
- Confirm the total number of shares outstanding post-offering to assess dilution impact.
- Review the full text of the Underwriting Agreement (Exhibit 1.1) for specific lock-up periods or restrictive covenants.
- Check subsequent filings for the intended use of proceeds and any impact on the Company's cash runway.